|
SKYE | Skye Bioscience, Inc. |
|
|
SKYE | Skye Bioscience, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ -0.14 |
| Leverage | 104.51% |
| Market Cap | $ 3.5m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -50.3m |
| Margin | 116756.96% |